Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis

BACKGROUND: Recent approval and adoption of pangenotypic direct acting antivirals (DAAs) necessitated a revision of the 2015 World Health Organization guidelines for the management of persons with hepatitis C virus (HCV) infection. METHODS: We searched MEDLINE, EMBASE, CENTRAL, and relevant conferen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoratti, Michael J., Siddiqua, Ayesha, Morassut, Rita E., Zeraatkar, Dena, Chou, Roger, van Holten, Judith, Xie, Feng, Druyts, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948236/
https://www.ncbi.nlm.nih.gov/pubmed/31922124
http://dx.doi.org/10.1016/j.eclinm.2019.12.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948236/
https://www.ncbi.nlm.nih.gov/pubmed/31922124
http://dx.doi.org/10.1016/j.eclinm.2019.12.007

Ejemplares similares